These molecular networks with reported functionality in tumor progression and treatment resistance prompted us to investigate protein co-expression levels and patterns of Sox2, EpCAM and vimentin in HNSCC. This evidence concerns the gene EPCAM and head and neck squamous cell carcinoma.